Wynn A. Volkert

6.0k citations

136 papers · 5.0k indexed · 2 hit papers · h-index 37

Radiology, Nuclear Medicine and Imaging top 0.2%
Oncology top 2%
Pulmonary and Respiratory Medicine top 2%
Molecular Biology top 10%
Organic Chemistry top 2%

Co-authors: Timothy J. Hoffman Richard A. Holmes Kattesh V. Katti Charles J. Smith Gary L. Sieckman A.R. Ketring D.E. Troutner Hariprasad Gali
Topics: Radiopharmaceutical Chemistry and Applications (92 papers)Medical Imaging Techniques and Applications (30 papers)Medical Imaging and Pathology Studies (28 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Oncology Inorganic Chemistry
Journals: Chemical Reviews Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States India United Kingdom

In The Last Decade

Wynn A. Volkert

136 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic Radiopharmaceuticals

1999 644 citations Wynn A. Volkert, Timothy J. Hoffman profile →
Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

1987 407 citations Richard A. Holmes, Wynn A. Volkert et al. profile →

Peers

Countries citing papers authored by Wynn A. Volkert

Since Specialization

Citations

This map shows the geographic impact of Wynn A. Volkert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wynn A. Volkert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wynn A. Volkert more than expected).

Fields of papers citing papers by Wynn A. Volkert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wynn A. Volkert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wynn A. Volkert. The network helps show where Wynn A. Volkert may publish in the future.

Co-authorship network of co-authors of Wynn A. Volkert

This figure shows the co-authorship network connecting the top 25 collaborators of Wynn A. Volkert. A scholar is included among the top collaborators of Wynn A. Volkert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wynn A. Volkert. Wynn A. Volkert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TLD assessment of mouse dosimetry during microCT imaging 2008 ·Medical Physics ·Said Daibes Figueroa,Christopher T. Winkelmann,William H. Miller,Wynn A. Volkert,Timothy J. Hoffman	37
2	Evaluation of the Pharmacokinetic Effects of Various Linking Group Using the ¹¹¹In-DOTA-X-BBN(7−14)NH₂ Structural Paradigm in a Prostate Cancer Model 2008 ·Bioconjugate Chemistry ·Jered C. Garrison,Tammy L. Rold,Gary L. Sieckman,Farah Naz,(unknown),Said Daibes Figueroa,Wynn A. Volkert,Timothy J. Hoffman	49
3	Evaluation of Combined ¹⁷⁷ Lu-DOTA-8-AOC-BBN (7-14)NH ₂ GRP Receptor-Targeted Radiotherapy and Chemotherapy in PC-3 Human Prostate Tumor Cell Xenografted SCID Mice 2006 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown),(unknown),Charles J. Smith,Lixin Ma,Michael C. Perry,Wynn A. Volkert,Timothy J. Hoffman	29
4	Evaluation of Beta-Absorbed Fractions in a Mouse Model for ⁹⁰ Y, ¹⁸⁸ Re, ¹⁶⁶ Ho, ¹⁴⁹ Pm, ⁶⁴ Cu, and ¹⁷⁷ Lu Radionuclides 2005 ·Cancer Biotherapy and Radiopharmaceuticals ·William H. Miller,(unknown),Darrell R. Fisher,Marie-Anne Descalle,T.P. Daly,Jöerg Lehmann,Michael R. Lewis,Timothy J. Hoffman,(unknown),(unknown),Wynn A. Volkert	53
5	Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes 2005 ·Nuclear Medicine and Biology ·Charles J. Smith,Wynn A. Volkert,Timothy J. Hoffman	155
6	Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP2) chelate 2003 ·Applied Radiation and Isotopes ·Kanchan Kothari,Raghuraman Kannan,Nagavarakishore Pillarsetty,Timothy J. Hoffman,Nellie K. Owen,Kattesh V. Katti,Wynn A. Volkert	17
7	Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells 2003 ·Nuclear Medicine and Biology ·Charles J. Smith,Hariprasad Gali,Gary L. Sieckman,(unknown),Nellie K. Owen,(unknown),Wynn A. Volkert,Timothy J. Hoffman	90
8	In Vivo evaluation of an 111 In-labeled ST-peptide analog for specific-targeting of human colon cancers 2001 ·Nuclear Medicine and Biology ·Hariprasad Gali,Gary L. Sieckman,Timothy J. Hoffman,Nellie K. Owen,David T. Chin,Leonard R. Forte,Wynn A. Volkert	11
9	Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells 2001 ·Nuclear Medicine and Biology ·Timothy J. Hoffman,Thomas P. Quinn,Wynn A. Volkert	43
10	Rhodium-105 tetrathioether complexes: radiochemistry and initial biological evaluation 1999 ·Nuclear Medicine and Biology ·Niranjan Goswami,(unknown),Wynn A. Volkert,Roger Alberto,Walter Nef,Silvia S. Jurisson	14
11	198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals 1998 ·Nuclear Medicine and Biology ·Douglas E. Berning,Kattesh V. Katti,Wynn A. Volkert,C. Higginbotham,A.R. Ketring	24
12	In vitro and in vivo characterization of novel water-soluble dithio-bisphosphine 99mTc complexes 1997 ·Nuclear Medicine and Biology ·Charles J. Smith,Na Li,Kattesh V. Katti,C. Higginbotham,Wynn A. Volkert	18
13	Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats 1997 ·Nuclear Medicine and Biology ·(unknown),(unknown),C. Higginbotham,Andrew J. Grall,(unknown),Jean F. Vollano,(unknown),L. A. Ochrymowycz,A.R. Ketring,Matthew J. Abrams,Wynn A. Volkert	18
14	An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates 1996 ·Nuclear Medicine and Biology ·(unknown),Niranjan Goswami,Wynn A. Volkert,E. O. Schlemper,A.R. Ketring,Charles L. Barnes,Silvia S. Jurisson	25
15	In vitro and in vivo characterization of a 99mTc complex with tris(hydroxymethyl)phosphine (THP) 1996 ·Nuclear Medicine and Biology ·Douglas E. Berning,Kattesh V. Katti,(unknown),(unknown),V. Sreenivasa Reddy,Wynn A. Volkert	29
16	Comparisons of ¹⁰⁵Rh(III) Chloride Complexation with [14]aneNS₃, [14]aneN₂S₂ and [14]aneN₄ Macrocycles in Aqueous Solution 1996 ·Radiochimica Acta ·(unknown),(unknown),Wynn A. Volkert,L. A. Ochrymowycz,Colin Barnes,A.R. Ketring	16
17	Transition metal chemistry of main group hydrazides, part 14: Evaluation of new Tc-99m chelates of thiol functionalized phosphorus hydrazides 1995 ·Nuclear Medicine and Biology ·(unknown),(unknown),Wynn A. Volkert,A.R. Ketring,Richard A. Holmes,Kattesh V. Katti	3
18	Some observations on the instability of 99mTc-complexes of propylene amine oxime (PnAO) 1994 ·Nuclear Medicine and Biology ·M.R.A. Pillai,E. O. Schlemper,Wynn A. Volkert	2
19	Synthesis, characterization and biodistribution studies of a neutral-lipophilic Tc-99m N3S2 chelate 1992 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·(unknown),(unknown),D.E. Troutner,A.R. Ketring,Wynn A. Volkert	1
20	Labeling of antibodies with 64Cu using a conjugate containing a macrocyclic amine chelating agent 1987 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·J. Fränz,(unknown),E. Kent Barefield,Wynn A. Volkert,Gary J. Ehrhardt,Richard A. Holmes	15

About Wynn A. Volkert

Wynn A. Volkert is a scholar working on Radiology, Nuclear Medicine and Imaging, Physical and Theoretical Chemistry and Oncology, having authored 136 papers that have together received 5.0k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (92 papers), Medical Imaging Techniques and Applications (30 papers) and Medical Imaging and Pathology Studies (28 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.2k citations), Oncology (1.6k citations) and Inorganic Chemistry (590 citations). Wynn A. Volkert has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Timothy J. Hoffman, Richard A. Holmes, Kattesh V. Katti, Charles J. Smith, Gary L. Sieckman, A.R. Ketring, D.E. Troutner, Hariprasad Gali, Gary J. Ehrhardt and Charles L. Barnes. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact